His primary areas of investigation include Internal medicine, Kidney disease, Endocrinology, Hemodialysis and Dialysis. His Internal medicine study combines topics in areas such as Gastroenterology and Cardiology. His Kidney disease research includes themes of Renal function, Diabetes mellitus, Endothelial dysfunction and Disease, Pathology.
The concepts of his Disease study are interwoven with issues in Developed country, Public health, Bioinformatics and Intensive care medicine. His Endocrinology study incorporates themes from Calcification, Apolipoprotein E and Toxicity. The study incorporates disciplines such as Cystatin C and C-reactive protein in addition to Dialysis.
The scientist’s investigation covers issues in Internal medicine, Kidney disease, Endocrinology, Dialysis and Hemodialysis. His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology and Cardiology. His Gastroenterology research includes elements of Homocysteine, Hyperhomocysteinemia and Surgery.
His Kidney disease research includes elements of Bioinformatics, Uremia, Intensive care medicine and Disease, Pathology. His Endocrinology research includes themes of Calcification, Apolipoprotein E and Parathyroid hormone. The concepts of his Dialysis study are interwoven with issues in Incidence, Renal replacement therapy, Hazard ratio, Kidney and Peritoneal dialysis.
Ziad A. Massy mainly focuses on Internal medicine, Kidney disease, Dialysis, Nephrology and Transplantation. His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology and Endocrinology. He studied Endocrinology and Calcification that intersect with Receptor.
Ziad A. Massy combines subjects such as Renal function, Intensive care medicine, Disease, Cholesterol and Cohort with his study of Kidney disease. His research investigates the connection with Dialysis and areas like Hazard ratio which intersect with concerns in Prospective cohort study and Proportional hazards model. His study in Nephrology is interdisciplinary in nature, drawing from both Guideline, Family medicine and Cardiology.
His primary scientific interests are in Kidney disease, Internal medicine, Dialysis, Kidney transplantation and Transplantation. His Kidney disease study combines topics in areas such as Nephrology, Diabetes mellitus, Intensive care medicine, Pathophysiology and Kidney. The study incorporates disciplines such as Disease, Microglia and Bioinformatics in addition to Kidney.
His study in Internal medicine concentrates on Survival rate, Cohort study, Confounding, Stage and Renal function. Ziad A. Massy interconnects Epidemiology and Incidence in the investigation of issues within Kidney transplantation. His Transplantation research incorporates themes from Dialysis patients and Confidence interval.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Colin Baigent;Martin J Landray;Christina Reith;Jonathan Emberson.
The Lancet (2011)
A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease
D. Fouque;K. Kalantar-Zadeh;J. Kopple;N. Cano.
Kidney International (2008)
Review on uremic toxins: Classification, concentration, and interindividual variability
Raymond Vanholder;Rita De Smet;Griet Glorieux;Angel Argilés.
Kidney International (2003)
Chronic kidney disease as cause of cardiovascular morbidity and mortality.
R. Vanholder;Z. Massy;A. Argiles;G. Spasovski.
Nephrology Dialysis Transplantation (2005)
Serum Indoxyl Sulfate Is Associated with Vascular Disease and Mortality in Chronic Kidney Disease Patients
Fellype C. Barreto;Daniela V. Barreto;Sophie Liabeuf;Natalie Meert.
Clinical Journal of The American Society of Nephrology (2009)
Cardiovascular disease after renal transplantation.
Bertram L. Kasiske;Carlos Guijarro;Ziad A. Massy;Michael R. Wiederkehr.
Journal of The American Society of Nephrology (1996)
Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?
Peter Stenvinkel;Juan Jesús Carrero;Jonas Axelsson;Bengt Lindholm.
Clinical Journal of The American Society of Nephrology (2008)
Vascular calcification in chronic kidney disease.
William G Goodman;Gerard London;Kerstin Amann;Geoffrey A Block.
American Journal of Kidney Diseases (2004)
Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study
Christophe Tribouilloy;Dan Rusinaru;Haïfa Mahjoub;Vicky Soulière.
European Heart Journal (2008)
Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease
David M. Good;Petra Zürbig;Àngel Argilés;Hartwig W. Bauer.
Molecular & Cellular Proteomics (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Université Paris-Saclay
Ghent University
National Academies of Sciences, Engineering, and Medicine
Hôpital Édouard-Herriot
Autonomous University of Madrid
Grenoble Alpes University
Grigore T. Popa University of Medicine and Pharmacy
Karolinska Institute
University of Würzburg
National Research Council (CNR)
École Normale Supérieure de Lyon
Seoul National University
Georgia Institute of Technology
Georgia Institute of Technology
The University of Texas at Dallas
University of Bergen
University of Lorraine
Gifu University
Keio University
University of Vienna
University of Florida
Oregon Health & Science University
Brown University
University of Tennessee at Knoxville
University of Florida
Harvard University